REFERENCES
- Bendayan, M., Ziv, E., Gingras, D., Ban-sanson, R., Bar-on, H., and Kidron, M. 1994. Biochemical and morphocytochemica l evidence for the intestinal absorption of insulin in control and diabetic rats—comparison between the effectivenes s of duodena l and colon mucosa. Diabetologia 37:119.
- Brown, L., Munoz, C., Siemer, L., Edelman, E., and Langer, R. 1986. Controlled release of insulin from polymer matrices—control of diabetes in rats. Diabetes 35:692.
- Choudhari, K. B., Labhesetwar, V., and Dorle, A. K. 1994. Liposomes as a carrier for administration of insulin: effect of formulation factors, J. Microencapsul. 11:319.
- Cunha, A. S., Grossiord, T. L., Puisiene, F., and Seiller, M. 1997. Insulin in w/o/w multiple emulsion biological activity after oral administration in normal and diabetic rats. J. Microencapsul. 14:32.
- Dileep, K. J., Rowsen Moses, L., and Sharma, C. P. 1998. Modulation of insulin release from chitosan/alginate microspheres. Trends in Biomater. Art. Org. 12:42.
- Gupta, D., Reju, J., and Baquer, N. Z. 1999. Modulation of some gluconeogeni c enzyme activities in diabetic rat liver and kidney: effect of antidiabetic com- pounds. Ind. J. Exp. Biol. 37:196.
- Hari, P. R., Chandy, T., and Sharma, C. P. 1996. Chitosan/calcium alginate beads for oral delivery of insulin. J. Appl. Polym. Sci. 59:1795.
- Jerry, N., Moses, L. R., Sharma, C. P., Sony, P., and Anitha, Y. 2000. Oral drug delivery system for insulin based on alginate microparticles: preparation, characterisation, in-vitro and in-vivo evaluation. Transact. 6th World Biomat. Congress.
- Lin, J. C., Sun, Y., Siddiqui, O., Chien, Y. W., Shi, W. M., and Li, J. 1988. Blood glucose control in diabetic rats by transdermal iontophoretic delivery of insulin. Int. J. Pharm. 44:197.
- Oh, I. J., Song, H. M., and Lee, K. C. 1994. Effect of 2-hydrox y propyl-cyclodextrins on the stability of postglandin E2 in solution. Int. J. Pharm 106:135.
- Otagiri, M., Imai, T., Matsuo, N., and Uekama, K. 1983. Improvemen t to some pharmaceutica l properties of Flurbiprofen by ¯- and ° -cyclodextrin s in hu- mans. Acta Pharm. Scand. 20:11.
- Rerup, C. C. 1970. Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol. Rev. 22:485.
- Takanaga, M., Serizava, Y., Azechi, Y., Ochiai, A., Kosaka, Y., Igarashi, P., and Mizushima, Y. 1998. Microparticle resins as a potential nasal drug delivery system for insulin. J. Control. Release 52:81.
- Uekama, K., Otagiri, M., Uemura, Y., Fujinaga, T., Arimori, K., Matsuo, N., Tasaki K., and Sugii, A. 1983. Improvemen t of oral bioavailability of pred- nisolone by ¯-cyclodextrin complexatio n in humans, J. Pharmacobiol. Dyn. 6:124.
- Vyas, S. P., Karajgi, J. S., Gogoi, P. J., and Jain, N. K. 1991. Development, char- acterization and evaluation of an autoregulator y delivery system for insulin. J. Microencapsul. 8:235.
- Watanabe, Y., Matsumoto, Y., Seki, M., Takase, M., and Matsumoto, M. 1992. Absorption enhancemen t of polypeptide drugs by cyclodextrins. I. Enhanced rectal absorption of insulin from hollow-type suppositories containing insulin and cyclodextrin s in rabbits. Chem. Pharm. Bull. 40:3042.
- Yamamoto, A., Luo, A., Dodele-Kashi, S., and Lee, V. H. L. 1989. Pharm. Exp. Ther. 249.